GK-1 Improves the Immune Response Induced by Bone Marrow Dendritic Cells Loaded with MAGE-AX in Mice with Melanoma

The aim of dendritic cell (DC) vaccination in cancer is to induce tumor-specific effector T cells that may reduce and control tumor mass. Immunostimulants that could drive a desired immune response are necessary to be found in order to generate a long lasting tumor immune response. GK-1 peptide, der...

Descripción completa

Detalles Bibliográficos
Autores principales: Piñón-Zárate, Gabriela, Herrera-Enríquez, Miguel Ángel, Hernández-Téllez, Beatriz, Jarquín-Yáñez, Katia, Castell-Rodríguez, Andrés Eliú
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230216/
https://www.ncbi.nlm.nih.gov/pubmed/25759825
http://dx.doi.org/10.1155/2014/158980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230216/
https://www.ncbi.nlm.nih.gov/pubmed/25759825
http://dx.doi.org/10.1155/2014/158980

Ejemplares similares